Brukinsa Europäische Union - Deutsch - EMA (European Medicines Agency)

brukinsa

beigene ireland ltd - zanubrutinib - waldenstrom macroglobulinemia - antineoplastische mittel - brukinsa as monotherapy is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy. brukinsa as monotherapy is indicated for the treatment of adult patients with marginal zone lymphoma (mzl) who have received at least one prior anti-cd20-based therapy. brukinsa as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukemia (cll).

Atomoxetin Sandoz 10 mg Hartkapsel Belgien - Deutsch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

atomoxetin sandoz 10 mg hartkapsel

sandoz - atomoxetine hydrochloride - hartkapsel - 10 mg - atomoxetine hydrochloride 11.428 mg - atomoxetine

Atomoxetin Sandoz 18 mg Hartkapsel Belgien - Deutsch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

atomoxetin sandoz 18 mg hartkapsel

sandoz - atomoxetine hydrochloride - hartkapsel - 18 mg - atomoxetine hydrochloride 20.57 mg - atomoxetine